Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/21 10:09:36 am
124.075 EUR   -0.42%
06:10aMERCK KGAA : Morgan Stanley reaffirms its Neutral rating
MD
02:55aMERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/16Physiomics Wins Contracts With Existing Customers
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : Goldman Sachs maintains a Sell rating

share with twitter share with LinkedIn share with facebook
09/28/2020 | 01:32am EDT

Krishna Chaitanya Arikatla from Goldman Sachs retains his negative opinion on the stock with a Sell rating. The target price differs slightly and is now set at EUR 102 versus EUR 100.

© MarketScreener with dpa-AFX Analyser 2020

Stocks mentioned in the article
ChangeLast1st jan.
MERCK KGAA -0.44% 124.1 Delayed Quote.18.27%
THE GOLDMAN SACHS GROUP, INC. -0.62% 206.73 Delayed Quote.-9.52%
share with twitter share with LinkedIn share with facebook
All news about MERCK KGAA
06:10aMERCK KGAA : Morgan Stanley reaffirms its Neutral rating
MD
02:55aMERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/16Physiomics Wins Contracts With Existing Customers
DJ
10/15MERCK : Global Head of R&D for Healthcare to Retire
DJ
10/15Global Glycobiology Market to Rise at 14.64% between 2020 and 2027
AQ
10/13MERCK : Launches Cell and Gene Therapy Platform
DJ
10/13MERCK KGAA : Barclays withdraws its Sell rating
MD
10/12Merck KgaA Licenses Genome-Editing Technology to Two Companies
DJ
10/09MERCK : Precigen Shares Gain 20% as Germany's Merck Raises Stake
DJ
10/09MERCK : Raises Precigen Stake to 14.8% With Note Conversion
DJ
More news
Financials
Sales 2020 17 314 M 20 529 M 20 529 M
Net income 2020 1 704 M 2 021 M 2 021 M
Net Debt 2020 10 875 M 12 894 M 12 894 M
P/E ratio 2020 30,6x
Yield 2020 1,07%
Capitalization 54 173 M 64 080 M 64 232 M
EV / Sales 2020 3,76x
EV / Sales 2021 3,48x
Nbr of Employees 57 523
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 126,24 €
Last Close Price 124,60 €
Spread / Highest target 20,4%
Spread / Average Target 1,32%
Spread / Lowest Target -18,9%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA18.27%64 080
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD123.45%22 185
KYOWA KIRIN CO., LTD.3.03%13 489
BETTA PHARMACEUTICALS CO., LTD.63.61%6 484
YUHAN CORPORATION28.12%3 331
RECIPHARM AB (PUBL)16.79%1 765